BVF INC/IL

13F Portfolio Filings

  • Most recent 13F
    Q1 2025
  • Location
    san francisco, CA
  • CIK
    0001056807
  • All SEC filings
Q1 2025
Quater
Holdings
VALUE
Top Holdings
Form Type
Date Filed
Filing Id

51

$2.45B
MLTX, AXSM, RVMD, KYMR
13F-HR
May 15, 2025
000092189525001528

53

$2.95B
MLTX, KYMR, RVMD, AXSM
13F-HR
Feb 14, 2025
000092189525000463

55

$3.42B
MLTX, KYMR, RVMD, MIRM
13F-HR
Nov 14, 2024
000092189524002698

60

$3.57B
MLTX, RVMD, KYMR, ISI
13F-HR
Aug 14, 2024
000092189524001815

62

$3.64B
MLTX, KYMR, RVMD, FDMT
13F-HR
May 15, 2024
000092189524001219

70

$4.00B
MLTX, RVMD, AXSM, PTGX
13F-HR
Feb 14, 2024
000092189524000477

69

$3.71B
MLTX, ISI, AXSM, IDYA
13F-HR
Nov 14, 2023
000092189523002623

67

$3.59B
MLTX, RVMD, AXSM, IDYA
13F-HR
Aug 14, 2023
000092189523001946

72

$2.74B
MLTX, KYMR, AXSM, RVMD
13F-HR
May 15, 2023
000092189523001220

78

$2.37B
MLTX, AXSM, RPTX, KYMR
13F-HR
Feb 14, 2023
000092189523000558

80

$2.42B
MLTX, ISI, GH RESEARCH PLC, KYMR
13F-HR
Nov 14, 2022
000092189522003025

79

$2.07B
RPTX, MLTX, RCUS, CGEM
13F-HR
Aug 15, 2022
000092189522002470

81

$2.50B
GH RESEARCH PLC, KYMR, RLAY, RCUS
13F-HR
May 16, 2022
000092189522001680

83

$2.76B
GH RESEARCH PLC, KYMR, RCUS, MERUS N V
13F-HR
Feb 14, 2022
000092189522000561

75

$2.56B
GH RESEARCH PLC, KYMR, OLMA, RCUS
13F-HR
Nov 15, 2021
000092189521002668

70

$2.67B
GH RESEARCH PLC, ARGX, OLMA, PTGX
13F-HR
Aug 16, 2021
000092189521002114

67

$2.67B
FPRX, OLMA, MERUS N V, XOMA
13F-HR
May 17, 2021
000092189521001374

68

$2.54B
OLMA, XOMA, KYMR, RLAY
13F-HR
Feb 12, 2021
000092189521000372

62

$1.84B
RLAY, SWTX, RPTX, KYMR
13F-HR
Nov 13, 2020
000092189520002920

57

$1.62B
SWTX, PRNB, ARGX, ISI
13F-HR
Aug 14, 2020
000092189520002253

57

$1.07B
PRNB, ISI, AC IMMUNE SA, SWTX
13F-HR
May 15, 2020
000092189520001448

57

$1.32B
ISI, SWTX, AC IMMUNE SA, PRNB
13F-HR
Feb 14, 2020
000092189520000569

59

$951.79M
MERUS N V, SWTX, ISI, AC IMMUNE SA
13F-HR
Nov 14, 2019
000092189519002786

56

$915.61M
MERUS N V, CYTK, 1832555D, AC IMMUNE SA
13F-HR
Aug 14, 2019
000092189519002231

53

$893.07M
1832555D, MERUS N V, BPMC, KURA
13F-HR
May 15, 2019
000092189519001497

55

$765.19M
CCXI, 1832555D, MERUS N V, KURA
13F-HR
Feb 14, 2019
000092189519000425

57

$1.14B
1832555D, CCXI, MERUS N V, CYTK
13F-HR
Nov 14, 2018
000092189518003059

51

$1.02B
CCXI, MERUS N V, 1832555D, CYTK
13F-HR
Aug 14, 2018
000092189518002318

43

$986.48M
CCXI, IRWD, 1832555D, BPMC
13F-HR
May 7, 2018
000092189518001588

43

$829.55M
1832555D, ANAB, BPMC, XOMA
13F-HR
Feb 14, 2018
000092189518000676

37

$786.73M
1832555D, BPMC, CCXI, ANAB
13F-HR
Nov 14, 2017
000092189517002664

34

$643.98M
BPMC, CCXI, 1832555D, ANAB
13F-HR
Aug 14, 2017
000092189517002146

30

$587.93M
BPMC, CCXI, CYTK, ANAB
13F-HR
May 15, 2017
000092189517001513

29

$497.73M
BPMC, CYTK, CCXI, 1832555D
13F-HR
Feb 14, 2017
000092189517000368

29

$530.67M
BPMC, CCXI, CYTK, 1832555D
13F-HR
Nov 14, 2016
000092189516006168

34

$469.39M
BPMC, CYTK, CCXI, EXEL 4.25 08/15/19
13F-HR
Aug 15, 2016
000092189516005495

32

$404.12M
BPMC, CNCE, CYTK, FORWARD PHARMA A/S
13F-HR
May 16, 2016
000092189516004561

30

$586.78M
BPMC, CCXI, CTI BIOPHARMA CORP, CNCE
13F-HR
Feb 16, 2016
000092189516003386

27

$495.01M
IRWD, CCXI, ONCOTHYREON INC, 1832555D
13F-HR
Nov 16, 2015
000092189515002554

30

$566.57M
1832555D, CCXI, BPMC, FORWARD PHARMA A/S
13F-HR
Aug 14, 2015
000092189515002011

30

$478.24M
1832555D, CCXI, IRWD, FORWARD PHARMA A/S
13F-HR
May 15, 2015
000092189515001376

31

$514.08M
IRWD, CCXI, 1832555D, LGND
13F-HR
Feb 17, 2015
000092189515000447

32

$481.63M
IRWD, RCPT, LGND, 1832555D
13F-HR
Nov 14, 2014
000092189514002431

29

$632.35M
IRWD, LGND, 1832555D, CCXI
13F-HR
Aug 14, 2014
000092189514001872

28

$645.12M
LGND, IRWD, CCXI, AMGN
13F-HR
May 15, 2014
000092189514001203

26

$571.59M
LGND, IRWD, EXEL 4.25 08/15/19, CCXI
13F-HR
Feb 14, 2014
000092189514000355